Robert A. Gross, MD, PhD, FANA, FAAN, graduated from Harvard College in 1975 with an AB in biology, summa cum laude, and from Washington University, MD and PhD (pharmacology) in 1981. After his internship at the Jewish Hospital in St. Louis, he completed his neurology residency at the Massachusetts General Hospital, where he served as chief resident. Faculty positions followed at the University of Michigan and the University of Minnesota, followed by the University of Rochester Medical Center (1994).  

Research interests have centered on various aspects of cellular neuropharmacology and, collaboratively, on mechanisms of excitotoxicity and chemobrain. He participated in clinical trials of novel anticonvulsants and served on a multi-center task force to design trials to compare brand to generic AEDs. He was the recipient of the S. Weir Mitchell Award of the American Academy of Neurology (AAN) in 1988. 

He sees patients in the Strong Epilepsy Center, and is the associate chair for academic affairs in neurology. 

Gross' educational efforts are diverse. He founded and directs the Academic Research Track; funded by URMC's Clinical and Translational Science Award, this supports medical students for a year-out mentored experience in medical research. He helps direct and lectures (neuropharmacology) in the medical student course “Mind, Brain and Behavior.” He directs a novel basic science course for fourth-year medical students, “Process of Discovery,” in which students design cutting-edge research programs to address gaps in clinical care. He also teaches in AAN Annual Meeting courses, including the Career Development symposium. 

He served as an associate editor of Neurology® for eight years, two of which were as deputy editor, and is the current editor-in-chief of the Neurology journals. 

Gross is a fellow of the AAN and American Neurological Association, and a member of the American Epilepsy Society. He has appeared on the PBS program “Second Opinion” and on local radio shows on the topic of epilepsy.